Donor pretreatment with leflunomide has an adverse effect on rat cardiac allograft survival

Transplant Immunology

Volumn 5, Issue 2, 1997, Pages 136-141

  DeRoover, Arnaud ^a   Williams, Ann ^a   Hubscher, Stefan ^a   Candinas, Daniel ^a   Antoniou, Efstathios ^a   Howie, Alexander ^a   Drayson, Mark ^b   McMaster, Paul ^a   D'Silva, Milbhor ^a,c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^c Transplant Microsurgery Laboratory   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEFLUNOMIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0030748436     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(97)80054-8     Document Type: Article

References (31)

1. Guttman RD, Carpenter CB, Lindquist RR, Merril JP. An immunosuppressive site of action of heterologous antilymphocyte serum. Lancet 1967; i: 248.
2. Zincke H, Woods JE. Attempted immunological alteration of canine renal allograft donors. Transplantation 1974; 18: 480.
3. Beyer MM, Friedman EA. Prolonged survival of rabbit skin and kidney allografts following donor treatment with cytosine arabinoside. Transplantation 1975; 19: 60.
4. Soots A, Pekka H. Prolongation of rat cardiac allograft survival by donor pretreatment. Transplantation 1978; 25: 259.
5. McKenzie JL, Beard MEJ, Hart DNJ. The effect of donor pretreatment on interstitial dendritic cell content and rat cardiac allograft survival. Transplantation 1984; 38: 371-76.
6. Stegall MD, Tezuka K, Oluwole SF et al. Interstitial class II-positive cell depletion by donor pretreatment with gamma irradiation. Transplantation 1990; 49: 246-51.
7. Tyerman K, Barron PT, Da Costa M et al. Prolongation of rat cardiac allograft survival by pretreatment of the donor to reduce class II antigen expression and dendritic cell content. Transplant Proc 1990; 22: 2325.
8. Krzymanski M, Waaga AM, Ulrichs K et al. The influence of MHC class II antigen blockade by perfusion with a monoclonal antibody on rat renal graft survival. Transplant Int 1991; 4: 180-85.
9. Kahn DR, Forrest DE, Otto DA. Prolonged survival of rat cardiac allografts by donor pretreatment with methotrexate. Transplantation 1991; 51: 697-700.
10. Pollak R, Blanchard JM, Mozes MF. Strategies used to alter the immunogenicity of vascularized organ allografts. Transplant Proc 1987; 19: 258-61.
11. Chong AS, Xiao F, Xiulong X, Williams JW. In vivo and in vitro immunosuppression with leflunomide. In: Sollinger H, Przepiorka D, eds. Recent developments in transplantation medicine. Glenview, IL: Physicians & Scientists Publishing Co., 1994: 163.
12. Wright JR, Kearns H, McDonald AS. Leflunomide and cyclosporine A prolong fish-to-mouse islet xenograft. Transplant Proc 1994; 26: 1310.
13. Kuchle CC, Thoenes GH, Langer KH, Schorlemmer H-U, Bartlett RR, Schleyerbach R. Prevention of kidney and skin graft rejection in rats by leflunomide, a new immunomodulating agent. Transplant Proc 1991; 23: 1083-86.
14. Schorlemmer H-U, Seiler FR, Bartlett RR. Prolongation of allogeneic transplanted skin grafts and induction of tolerance by Leflunomide, a new immunosuppressive isoxazol derivative. Transplant Proc 1993; 25: 763-67.
15. Lin Y, Vandeputte M, Waer M. Effect of lefunomide in T-independent xenoantibody formation in rats receiving hamster heart xenografts. Transplant Proc 1996; 28: 952.
16. D'Silva M, Candinas D, Achilleos O et al. The immunomodulatory effect of leflunomide in rat cardiac allotransplantation. Transplantation 1995; 60: 430-37.
17. Ono K, Lindsey ES. Improved techniques of heart transplant in rats. J Thorac Cardiovasc Surg 1969; 57: 225.
18. Morrisey PE, Gollin G, Brusett K, Marks WH. Prolongation of allograft survival in rat heterotopic heart transplantation by TLCK, a serine protease inhibitor. Transplantation 1994; 57: 631.
19. Barclay AN. The localization of populations of lymphocytes defined by monoclonal antibodies in rat lymphoid tissues. Immunology 1981; 42: 593-600.
20. McMaster WR, Williams AF. Identification of Ia glycoproteins in rat thymus and purification from rat spleen. Eur J Immunol 1979; 9: 426.
21. Milton AD, Fabre JW. Massive induction of donor-type class I and class II histocompatibility complex antigens in rejecting cardiac allografts in the rat. J Exp Med 1985; 161: 98-112.
22. Tanaka T, Masuko T, Yagita H, Tamura T, Hashimoto Y. Characterization of a CD3-like rat T cell surface antigen recognized by a monoclonal antibody. J Immunol 1989; 142: 2791-95.
23. Dijkstra CD, Dopp EA, Joling P, Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Adv Exp Med Biol 1985; 186: 409-19.
24. Beelen RH, Eestermans IL, Dopp EA, Dijkstra CD. Monoclonal antibodies ED1, ED2 and ED3 against rat macrophages: expression of recognized antigens in different stages of differentiation. Transplant Proc 1987; 19: 3166-70.
25. Mason DY, Comans-Bitter WM, Cordell JL, Verhoeven MAJ, van Dongen JJM. Antibody L26 recognizes an intracellular epitope on the B-cell-associated CD20 antigen. Am J Pathol 1990; 136: 1215-22.
26. Ochiai T, Nakajima K, Nagata M, Hori S, Asano T, Isono K. Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats. Transplantation 1987; 44: 734-38.
27. deBruin RWF, Saat RE, Heineman E, Jeekel J, Marquet RL. Effects of donor pretreatment with antilymphocyte serum and cyclosporin on rejection and graft-versus-host disease after small bowel transplantation in immunosuppressed and non immunosuppressed rats. Transplant Int 1993; 6: 22-25.
28. Tyerman K, Barron PT, Da Costa M et al. Prolongation of rat cardiac allograft survival by pretreatment of the donor to reduce class II antigen expression and dendritic cell content. Transplant Proc 1990; 22: 2325.
29. Burris DE, Gruel SM, Rao VK. Persistence of dendritic cells and allograft antigenicity despite prolonged interim hosting of cardiac allografts in rats. Transplantation 1989; 47: 1085-87.
30. Tilney NL. Patterns of lymphatic drainage in the adult laboratory rat. J Anat 1971; 109: 369.
31. Smith ME, Martin AF, Ford WL. Migration of lymphoblasts in the rat. Monogr Allergy 1980: 16: 203-32.